All News about Merck & Co![]()
Looking Into Merck & Co's Recent Short Interest
December 25, 2023
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
Exposures
Product Safety
![]()
Merck Provides U.S. Regulatory Update on Gefapixant
December 20, 2023
From Merck & Co., Inc.
Via Business Wire
![]()
Merck to Participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference
December 20, 2023
From Merck & Co., Inc.
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Contaminated Vaccines: FDA Reportedly Finds Cleaning And Expiry Lapses At Moderna's Massachusetts Facility
December 16, 2023
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]()
FDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patients
December 15, 2023
Via Benzinga
Exposures
Product Safety
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|